Comparison of Tc-99m sestamibi and TI-201 uptake in multiple myeloma.
The authors report abnormal Tc-99m sestamibi (MIBI) and TI-201 uptake in a 62-year-old patient with histologically and biochemically proved myeloma. TI-201 imaging was undertaken for tumor evaluation, and 3 days later a Tc-99m MIBI study showed diffuse and focal marrow uptake with focal skull lesions, whereas TI-201 did not show skull lesions. After treatment, follow-up Tc-99m MIBI whole-body imaging was performed and the marrow uptake was decreased.
Chun
K A
KA
Department of Nuclear Medicine, Yeungnam University Hospital, Taegu, Korea.
Cho
I H
IH
Won
K C
KC
Lee
K H
KH
Lee
H W
HW
Hyun
M S
MS
Hayashida
K
K
D001853:Bone Marrow / Q000000981:diagnostic imaging; D005260:Female; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000532:radiotherapy; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi; D013794:Thallium Radioisotopes
D019275:Radiopharmaceuticals; D013794:Thallium Radioisotopes; D017256:Technetium Tc 99m Sestamibi